Buy Retinol Acetate (Vitamin A) bottle 50 ml
  • Buy Retinol Acetate (Vitamin A) bottle 50 ml


1498 Items
Dosage form
Brand & Manufacturer
Package Size
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Retinol acetate solution in oil has the effect of compensating for vitamin A deficiency. Regulation of vitamin A-dependent metabolic processes.


Hypovitaminosis A, infectious diseases (measles, dysentery, tracheitis, bronchitis, pneumonia); skin diseases (burns, frostbite, wounds, skin tuberculosis, hyperkeratosis, ichthyosis, psoriasis, pyoderma, some forms of eczema); eye diseases (retinitis pigmentosa, hemeralopia, xerophthalmia, keratomalacia, conjunctivitis); chronic enterocolitis, hepatitis.


1 ml of solution contains retinol acetate 3.44% -100000 IU

Retinol is marketed under different brands and generic names, and comes in different dosage forms:

Brand nameManufacturerCountryDosage form
Retinol Acetate Vitamin A) (Marbiopharm Russia bottle
Videstim Retinoids Russia ointment
Retinol Palmitate Retinoids Russia vials

No customer reviews for the moment.

Write your review

Write your review


Dosage and Administration

The use of the drug should be under the supervision of a physician. The drug is taken orally after a meal early in the morning or late in the evening.
1 drop of the drug from a dropper or an eye dropper contains retinol palmitate of about 3,300 IU.
1 mg of retinol palmitate corresponds to 1817 IU.
With mild to moderate avitaminosis
Therapeutic doses for adults with mild to moderate avitaminosis are up to 33,000 IU / day.
For children - 1000-5000 IU / day. depending on age.
For eye diseases
Assign an adult - 50000-100000 IU per day and at the same time 0.02 g of riboflavin.
In dermatology in the treatment of acne and ichthyosiform erythrodermia
In adults, 100000-300000 IU / day.
Children 5,000-10,000 IU / kg per day.
For skin diseases
Assign adults per day to 50,000-100,000 IU of retinol palmitate.
In Gastroenterology
At 50,000 IU per day.
Single doses of retinol palmitate should not exceed 50,000 IU for adults and 5,000 IU for children.
Daily doses for adults are 100,000 IU and 20,000 IU for children.


Hypersensitivity to the drug.
Hypervitaminosis A.
Chronic pancreatitis.
Acute inflammatory skin diseases.
Use with caution when:
Heart failure II-III Art.
Viral hepatitis.
Renal failure.
In old age.
In childhood.

Drug interactions

During long-term tetracycline therapy, it is not recommended to prescribe vitamin A (the risk of developing intracranial hypertension increases).
Salicylates and glucocorticosteroids reduce the risk of side effects.
Kolestiramin, Kolestipol, mineral oils, neomycin reduce the absorption of vitamin A (may require an increase in dose).
Oral contraceptives increase the concentration of vitamin A in plasma.
Isotretinoin increases the risk of a toxic effect.
Vitamin E reduces toxicity, absorption, deposition in the liver and the use of vitamin A; high doses of vitamin E can reduce the supply of vitamin A in the body.
Weakens the effect of calcium preparations, increases the risk of hypercalcemia.

  • Active ingredient: Retinol

Studies and clinical trials of Retinol (Click to expand)

  1. Quantitative analysis of retinol and retinol palmitate in vitamin tablets using 1H-nuclear magnetic resonance spectroscopy
  2. Sample preparation for routine high-performance liquid chromatographic determination of retinol palmitate in emulsified nutritional supplements by solid-phase extraction using monosodium l-glutamate as dissolving agent
  3. Development of a method for quantitation of retinol and retinyl palmitate in human serum using high-performance liquid chromatography–atmospheric pressure chemical ionization–mass spectrometry
  4. Simultaneous determination of retinol acetate, retinol palmitate, cholecalciferol, α-tocopherol acetate and alphacalcidol in capsules by non-aqueous reversed-phase HPLC and column backflushing
  5. A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy
  6. Unoccluded Retinol Penetrates Human Skin In Vivo More Effectively Than Unoccluded Retinyl Palmitate or Retinoic Acid.
  7. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer
  8. Determination of retinol, retinyl palmitate, and retinoic acid in consumer cosmetic products
  9. Allergic contact dermatitis from tocopheryl acetate (vitamin E) and retinol palmitate (vitamin A) in a moisturizing cream
  10. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats
  11. Simultaneous determination of retinol, retinyl palmitate and β-carotene in rat serum treated with 7,12-dimethylbenz[a]anthracene andHypericum PerforatumL. by high-performance liquid chromatography with diode-array detection
  12. The effect of α tocopherol, all-trans retinol and retinyl palmitate on the non enzymatic lipid peroxidation of rod outer segments
  13. Characterization of Esterase and Alcohol Dehydrogenase Activity in Skin. Metabolism of Retinyl Palmitate to Retinol (Vitamin A) During Percutaneous Absorption
  14. HPLC determination of tocopherol, retinol, dehydroretinol and retinyl palmitate in tissues of lake char (Salvelinus namaycush) exposed to coplanar 3,3′,4,4′,5-pentachlorobiphenyl
  15. The effect of vitamin A on fusion of mouse palates. II. Retinyl palmitate, retinol, and retinoic acid in vitro
  16. Intestinal absorption of retinol and retinyl palmitate in the rat. Effects of tetrahydrolipstatin
  17. The effect of 3,4,3′,4′-tetrachlorobiphenyl on plasma retinol and hepatic retinyl palmitate hydrolase activity in female Sprague-Dawley rats
  18. Variations in pattern of regeneration from different proximo-distal levels of limbs in young frog tadpoles treated with retinol palmitate: I.A. Niazi and K.K. Sharma. Department of Zoology, University of Rajasthan, Jaipur 302004, India
  19. Successful desensitization in a patient with lenalidomide hypersensitivity
  20. Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo
  21. Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy
  22. Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma
  23. Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
  24. Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G)

Customers who bought this product also bought:

8 other products in the same category: